ClinicalTrials.Veeva

Menu

Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report

J

junya mita

Status

Completed

Conditions

Gallbladder Cancer

Treatments

Procedure: laparoscopic whole-layer cholecystectomy

Study type

Observational

Funder types

Other

Identifiers

NCT05559229
oitaRCH

Details and patient eligibility

About

Alpha-fetoprotein (AFP) can become elevated in hepatocellular carcinoma (HCC), yolk sac tumors and other malignant tumors of various organs. Herein, the investigator present a case of AFP-producing gallbladder carcinoma with signet ring cells successfully treated with laparoscopic whole-layer cholecystectomy.

Enrollment

1 patient

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

The study eligibility criteria for patient were as follows: AFP-producing gallbladder carcinoma (cT2aN0M0, cStage IIa, UICC 8th) or gallbladder metastasis from HCC.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems